Octreotide pamoate

Synonyms: SMS 201-995 pamoate
Octreotide (SMS 201-995) pamoate 是一种合成八肽生长抑素类似物,作为生长抑素受体 (somatostatin receptor) 激动剂,可与主要亚型 2、3、5 的生长抑素受体结合,增强 Gi 活性并降低胞内 cAMP 的产生,具有抗肿瘤活性,可介导细胞凋亡 (apoptosis),也可用于肢端肥大症的疾病研究。
产品编号: MS-W70712 CAS No.: 135467-16-2 分子式: C49H66N10O10S2.xC23H16O6
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

Octreotide (SMS 201-995) pamoate 是一种合成八肽生长抑素类似物,作为生长抑素受体 (somatostatin receptor) 激动剂,可与主要亚型 2、3、5 的生长抑素受体结合,增强 Gi 活性并降低胞内 cAMP 的产生,具有抗肿瘤活性,可介导细胞凋亡 (apoptosis),也可用于肢端肥大症的疾病研究。

生物实验数据

生物活性 Octreotide (SMS 201-995) pamoate is a synthetic octapeptide somatostatin analog that acts as a somatostatin receptor agonist, binding to somatostatin receptors primarily of subtypes 2, 3, and 5, enhancing Gi activity and reducing intracellular cAMP production, and exhibiting antitumor activity by mediating apoptosis (apoptosis), and it can also be used for disease research on acromegaly.
IC50 & Target

SSTR2

 

SSTR3

 

SSTR5

 

体外研究
(In Vitro)

Octreotide pamoate (10 8mM, 6 hours) induces phosphorylated glycogen synthase kinase 3β (GSK3β) phosphorylation and increases glycogen synthase (GS) activity.

Western Blot Analysis

Cell Line: Human hepatoblastoma HepG2 cell line
Concentration: 10‑8mM
Incubation Time: 6 hours
Result: Increased the protein expression levels of phosphorylated‑Akt and GSK3β by 140.8% and 12.2%, respectively and the mRNA level of GS also increased.
体内研究
(In Vivo)

Octreotide pamoate (subcutaneous injection, 30 mg/kg, once) can inhibit tumor growth significantly with no effect on body weight.
Octreotide pamoate (intramuscular injection, 60 mg/kg, every 21 days, 42 days) inhibits serum insulin-like growth factor (IGF-I) without toxicity in dogs with appendicular osteosarcoma (OSA).
Octreotide pamoate (subcutaneous injection, 40 μg/kg, Every 12 hours, 8 days) improves hepatic glycogen synthesis in obese male Sprague Dawley (SD) rats.

Animal Model: Female nude mice (nu/nu Balbc-A weighing 19-22 g)
Dosage: 30 mg/kg
Administration: Subcutaneous injection; once
Result: Showed that the average volume of tumors treated was 25.8% of the control group and no effect on body weight.
Animal Model: Dogs with appendicular OSA
Dosage: 60 mg/kg
Administration: Intramuscular injection; every 21 days; 42 days
Result: Resulted in a 43% decrease in mean serum IGF-I compared with mean baseline concentrations.
Animal Model: Male Sprague‑Dawley (SD) rats (3 weeks; 40-60 g)
Dosage: 40 μg/kg
Administration: Subcutaneous injection; every 12 hours; 8 days
Result: Significantly improved fat deposition and reduced lipid infiltration.

化学信息

分子式 C49H66N10O10S2.xC23H16O6
CAS No. 135467-16-2
别名 SMS 201-995 pamoate

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础